search icon

    Market Snapshot

    • S&P Futures

      4,132.5

    • Dow Futures

      32,787

    • Nasdaq Futures

      13,107.75

    blog search icon

    Alpine Immune Sciences, Inc.

    (NASDAQ:ALPN)

    $8.71

    -$0.19

    -2.13%

    Alpine Immune Sciences, Inc. Chart

    ALPN Stock Price Today

    Alpine Immune Sciences, Inc. (ALPN) stock declined over -2.13% intraday to trade at $8.71 a share on NASDAQ. The stock opened with a gain of 0.58% at $9.01 and touched an intraday high of $9.028, falling -2.13% against the last close of $8.9. The stock went to a low of $8.65 during the session.

    Stock Snapshot

    $8.9

    Prev. Close

    262.35 Million

    Market Cap

    $8.65

    Day Low

    $9.01

    Open

    30.27 Million

    Number of Shares

    $9.028

    Day High

    -

    P/E ratio

    -1.77

    EPS (TTM)

    5.67

    Cash Flow per Share

    5.14

    Free Float in %

    4.20

    Book Value

    66,508

    Volume

    Alpine Immune Sciences, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-08-08$9.01$9.028$8.65$8.7166,508
    2022-08-05$8.66$9.08$8.66$8.967,100
    2022-08-04$8.98$9.22$8.64$8.84113,900
    2022-08-03$8.34$9$8.34$8.81104,300
    2022-08-02$7.71$8.29$7.63$8.2108,800
    2022-08-01$7.89$7.94$7.73$7.8267,100
    2022-07-29$8.05$8.05$7.705$7.95107,400
    2022-07-28$8.34$8.35$7.85$8.126,500
    2022-07-27$8.26$8.421$7.985$8.347,700
    2022-07-26$7.99$8.225$7.94$8.0621,600

    Contact Details

    188 East Blaine Street
    Suite 200
    Seattle, WA 98102
    United States

    Webiste:ALPN

    206 788 4545

    Company Information

    Employees-

    Beta1.59

    Sales or Revenue33.87 Million

    5Y Sales Change51.4%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated autoimmune/inflammatory diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the research, development, and commercialization of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

    Frequently Asked Questions

    icon

    What is the current Alpine Immune Sciences, Inc. (ALPN) stock price?

    Alpine Immune Sciences, Inc. (NASDAQ: ALPN) stock price is $8.71 as of the last check on Monday, August 8. During the trading session, ALPN stock reached the peak price of $9.028 while $8.65 was the lowest point it dropped to.

    icon

    ALPN's industry and sector of operation?

    The NASDAQ listed ALPN is part of Biotechnology industry that operates in the broader Health Care sector. Alpine Immune Sciences, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases.

    icon

    Who are the executives of ALPN?

    Dr. Mitchell H. Gold M.D.
    Exec. Chairman & CEO
    Dr. Stanford Peng M.D., Ph.D.
    Pres and Head of R&D
    Mr. Paul Rickey
    Sr. VP, CFO, Treasurer & Sec.
    Dr. Wayne R. Gombotz
    Chief Technology Officer

    icon

    What is the ALPN stock price today?

    ALPN stock traded closed the last session at $8.71, which is -$0.1899999999999995 or -2.1348314606741514% lower than its previous close of $8.9. ALPN's current trading price is 45.17% lower than its 52-week high of $14.4 where as its distance from 52-week low of 6% is -39.51%.

    icon

    How many employees does ALPN have?

    Number of ALPN employees currently stands at -. ALPN operates from 188 East Blaine Street, Suite 200, Seattle, WA 98102, United States.

    icon

    Link for ALPN official website?

    Official Webiste of $ALPN is: https://www.alpineimmunesciences.com

    icon

    How do I contact ALPN?

    ALPN could be contacted at ALPN operates from 188 East Blaine Street, Suite 200, Seattle, WA 98102, United States, or at phone #206 788 4545 and can also be accessed through its website.

    icon

    How many shares of ALPN are traded daily?

    ALPN stock volume for the day was 66,508 shares while in the previous session number of ALPN shares traded was 66,508 . The average number of ALPN shares traded daily for last 3 months was 96 Thousands.

    icon

    How much did ALPN change today?

    The percentage change in ALPN stock occurred in the recent session was -2.1348314606741514% while the dollar amount for the price change in ALPN stock was -$0.1899999999999995.

    icon

    What price range ALPN stock been trading in?

    In the recent session, the day high for ALPN stock was $9.028 while the low for ALPN stock touched on the day was $8.65.

    icon

    What is the market cap of ALPN currently?

    The market value of ALPN currently stands at 262.35 Million with its latest stock price at $8.71 and 30.27 Million of its shares outstanding.